Microsites · healthcare · LATAMJul 202610 min read365 words

Mirror sites (1:1 microsites) for Series B companies: scaling without breaking for healthcare and life sciences in Latin America

How Series B companies scale mirror sites (1:1 microsites) across regions and teams without losing the discipline that made it work at Series A. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install mirror sites (1:1 microsites) has to be shaped to that reality from day one.

Series B is the stress test for mirror sites (1:1 microsites). What worked at fifteen people fails at fifty unless the operating rhythm is deliberate.

The Series B move is to separate the model owner from the operators. One senior human owns strategy, meeting rate from account-specific URLs, and the weekly review; a small team runs the machine.

Add a second geography or segment only when the first one is producing a defensible number for two full quarters. Not before.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Mirror sites (1:1 microsites) is only useful here when it is pointed at both constraints at once.

Governance appears at Series B — that is fine, provided it accelerates rather than slows. The test is whether reviews still make decisions or just distribute updates.

The Series B failure mode of mirror sites (1:1 microsites) is using them as brochures instead of sales rooms, amplified by headcount. Fix the root cause; do not paper over it with more people.

Compensation begins to matter now. Pay operators on meeting rate from account-specific URLs outcomes, not on effort. Effort-based comp at Series B produces theatre.

A well-run mirror sites (1:1 microsites) function at Series B is the moat that survives to Series C. Companies that skip this discipline burn through raises trying to buy it back.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing mirror sites (1:1 microsites) deliberately for this market rather than importing a playbook designed for somewhere else.

mirror sites1:1 micrositespersonalized landing pagesmirror sites for series Bscaling GTMmirror sites for healthcare and life sciencesmirror sites in Latin Americahealthcare and life sciences growth in Latin America

Frequently asked questions

Microsites · healthcare · LATAM — answered

Does mirror sites (1:1 microsites) work for healthcare and life sciences in Latin America?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
How does mirror sites (1:1 microsites) change at Series B?
Ownership separates from execution; operating rhythm gets more deliberate; governance appears.
When should we expand to a second region?
After the first region delivers two straight quarters of defensible meeting rate from account-specific URLs.
What compensation model works for mirror sites (1:1 microsites) operators at Series B?
Outcome-linked on meeting rate from account-specific URLs, not activity-based.
What is the Series B stress point?
Using them as brochures instead of sales rooms, amplified by headcount. Fix the root, not the symptom.
What is the LATAM-specific pitfall when running mirror sites (1:1 microsites) for healthcare?
Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.

Growth Broker editorial

Filed under microsites · healthcare · latam

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call